One of the key stages delaying and increasing costs in life sciences projects is equipment validation. In fact, it is one of the elements of project completion that project teams are most eager to compress because the value of every incremental improvement is so...
In an Australasian BioTechnology article, Facilities for a Strong Future, Emerson’s Michalle Adkins and Makarand Mujumdar share how pharmaceutical and biotech manufacturers can improve local capacity to meet the needs of the regions in which they operate.
As consumers of medicinal products of various kinds (vaccines, immunotherapies, tablets, capsules, cell therapies, etc.), we know that although product quality is important, reliable supply is also critical. A reliable supplier of therapeutic goods requires the...
Technology has continued to advance and provide ways to assist pharmaceutical & biopharmaceutical manufacturers with production readiness. Improper set up and qualification of automation and information management production applications cause start-up and product changeover delays, as well as slow performance during production runs.
Personalized medicine manufacturers are rapidly changing their manufacturing platforms to provide a new scale of production. In the Emerson Exchange Virtual Series, life sciences experts held an open Q&A on the trajectory of cell and gene therapies, and how a...
At a recent Emerson Exchange Americas virtual presentation session, Emerson’s Michalle Adkins and Alpana Desai presented on communicating with cross-cultural awareness.
Emerson’s Michalle Adkins will be discussing villains and heroes in knowledge management at the fully digital November 2-6, 2020 ISPE Annual Meeting and Expo.
Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
For pharmaceutical and biopharmaceutical manufacturers, the Life Sciences.NOW webinar series includes eight interactive discussions on digital plant technologies and will provide direction and updates on key manufacturing operation initiatives to improve operational performance, deliver cost effective quality and regulatory compliance and accelerate the product development pipeline.
Emerson’s Michalle Adkins, Benjamin Arriola & Brandon Haschke are co-authors along with professionals in leading biopharmaceutical manufacturing and suppliers in the BioPhorum work, In-line monitoring / real-time release testing in biopharmaceutical processes – prioritization and cost benefit analysis.
Emerson’s Michalle Adkins alerted me to the release of a new BioPhorum Knowledge Management white paper, A Test Case in CMC Business Processes from Late-Stage Development to Commercial Manufacturing.
For biopharmaceutical producers, creating value from the knowledge capture and dissemination is paramount. At the upcoming February 23-26 IFPAC [International Foundation Process Analytical Chemistry] conference, Emerson’s Michalle Adkins will present on the impact of KM in product and process development for biopharmaceutical manufacturers.
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.